Profilo
Zina Affas Besse currently holds the position of Director at Eyenuk, Inc. since 2022.
Also holds the role of Director at Alydia Health, Inc. The role of Director at LimmaTech Biologics AG has been held since 2023.
Serves as Partner at AXA IM Alts since 2022.
Acts as Advisor at LHGP Asset Management LLP (Private Equity).
Education includes undergraduate and doctorate degrees from the University of Nottingham Malaysia.
Posizioni attive di Zina Affas Besse
| Società | Posizione | Inizio |
|---|---|---|
Alydia Health, Inc.
Alydia Health, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices | Direttore/Membro del Consiglio | - |
Eyenuk, Inc.
Eyenuk, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diabetic retinopathy diagnostic devices | Direttore/Membro del Consiglio | 17/10/2022 |
LHGP Asset Management LLP (Private Equity)
LHGP Asset Management LLP (Private Equity) Investment ManagersFinance LHGP Asset Management seeks investment opportunities located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for late stage capital requirements with an average investment size of USD 10 million. | Consulente / Consigliere | - |
LimmaTech Biologics AG
LimmaTech Biologics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops vaccines for prevention of life-threatening diseases | Direttore/Membro del Consiglio | 09/10/2023 |
Formazione di Zina Affas Besse
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
LHGP Asset Management LLP (Private Equity)
LHGP Asset Management LLP (Private Equity) Investment ManagersFinance LHGP Asset Management seeks investment opportunities located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for late stage capital requirements with an average investment size of USD 10 million. | Finance |
Eyenuk, Inc.
Eyenuk, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diabetic retinopathy diagnostic devices | Health Technology |
Alydia Health, Inc.
Alydia Health, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices | Health Technology |
LimmaTech Biologics AG
LimmaTech Biologics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops vaccines for prevention of life-threatening diseases | Health Technology |
University of Nottingham Malaysia
University of Nottingham Malaysia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















